Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate

Clinical Trials

Pakistanis join final trials for China-made vaccine

26th November 2020

Thousands of volunteers are flocking to research hospitals across Pakistan to join final-stage clinical trials of a Chinese-made vaccine for...

Phase-3 trial of Bharat Biotechs Covaxin commences in AIIMS

by Content Team

26th November 2020

Phase-3 trial of Bharat Biotechs Covaxin commences in AIIMS

The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS here on Thursday with...

Pfizer Doses First Participant in Phase 3 Study Evaluating anti-TFPI Investigational Therapy

by Content Team

26th November 2020

Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances Into Phase III Clinical Trials

Pfizer Inc. announced that the first participant has been dosed in the Phase 3 BASIS study of marstacimab (PF-06741086), an...

AstraZeneca says AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19

by Content Team

26th November 2020

Fasenra shows consistent safety and sustained efficacy in long-term Phase III BORA trial in severe eosinophilic asthma

Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine...

Medicago and GSK announce start of Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate

by Content Team

16th November 2020

Phesi data show clinical trial suspensions continue to rise as COVID-19 impact on development persists

Medicago, a biopharmaceutical company headquartered in Quebec City, and GSK are pleased to announce the start of Phase 2/3 clinical...

Brazil’s health regulator allows resumption of Chinas Covid vaccine trial

by Content Team

16th November 2020

Pfizer and BioNTech Announce Agreement with the UK 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

Brazil's health regulator Anvisa announced the resumption of clinical trials of China's Sinovac COVID-19 vaccine. Quoting the latest official statement...

Affibody Announces Initiation of Confirmatory Phase 2 Trial of ABY-035 in Psoriatic Arthritis Patients

by Content Team

13th November 2020

Affibody Announces Initiation of Confirmatory Phase 2 Trial of ABY-035 in Psoriatic Arthritis Patients

Affibody AB, a clinical stage biopharmaceutical company, announced the initiation of its 52-week trial investigating the novel bispecific IL-17A inhibitor...

Sanofi and GSK to support COVAX with 200 million doses of adjuvanted, recombinant protein-based COVID-19 vaccine

by Content Team

6th November 2020

Sanofi and GSK to support COVAX with 200 million doses of adjuvanted, recombinant protein-based COVID-19 vaccine

Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global...

CureVac Reports Positive Interim Phase 1 Data for its COVID-19 Vaccine Candidate, CVnCoV

by Content Team

6th November 2020

AstraZeneca agrees to supply Europe with 400 million doses of COVID-19 vaccine

CureVac N.V. a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), announced...